
Pharmaceutical Technology Europe
Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.

Pharmaceutical Technology Europe
Chitosan is of pharmaceutical interest because of its positive attributes with respect to toxicity, biocompatibility and bioavailability.

Pharmaceutical Technology Europe
Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or in development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of a-lactose monohydrate were screened.

July 1st 2007

April 1st 2004